Psoriasis. Methotrexate, a folate antagonist, DMARDs, disease-modifying antirheumatic drug, a systemic therapy. Clobetasol propionate, potent topical corticosteroid for psoriatic plaques. Calcipotriol, a vitamin D analogue used topically. Cyclosporine, a calcineurin inhibitor used for severe recalcitrant psoriasis. Apremilast, an oral PDE4 inhibitor. Secukinumab, ixekizumab, biologics, specifically interleukin-17A inhibitors. Weight loss. Orlistat, a pancreatic lipase inhibitor, reduces dietary fat absorption. Metformin often used off-label for weight management in patients with insulin resistance. Liraglutide, a GLP-1 receptor agonist, approved for obesity management.